2016
DOI: 10.1021/acs.biomac.5b01541
|View full text |Cite
|
Sign up to set email alerts
|

Liposome-Cross-Linked Hybrid Hydrogels for Glutathione-Triggered Delivery of Multiple Cargo Molecules

Abstract: Novel, liposome-cross-linked hybrid hydrogels cross-linked by the Michael-type addition of thiols with maleimides were prepared via the use of maleimide-functionalized liposome cross-linkers and thiolated polyethylene glycol (PEG) polymers. Gelation of the materials was confirmed by oscillatory rheology experiments. These hybrid hydrogels are rendered degradable upon exposure to thiol-containing molecules such as glutathione (GSH), via the incorporation of selected thioether succinimide cross-links between the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
70
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 83 publications
(71 citation statements)
references
References 118 publications
1
70
0
Order By: Relevance
“…[189] Although GAG-based hydrogels have been employed for the parallel release of multiple growth factors, studies have shown that the sequential delivery of multiple growth factors would better mimic the temporal profile of the natural healing process. [190] Motivated by recent advances in hierarchically structured, multicomponent hydrogels and orthogonal degradation chemistries, GAG-based hydrogels with sequential release characteristics could be designed by incorporating a secondary nanoparticle domain (e.g., liposomes or PLGA nanoparticles) [191] into a GAG-based network and introducing multiple degradable linkages (e.g., wavelength-selective photocleavable units) [192] into the precursors. Combined with the inherent biological activities of GAGs, such GAG-based materials could provide physiologically relevant release profiles and spatial gradients of multiple growth factors, with the potential to improve tissue regeneration.…”
Section: Perspectivementioning
confidence: 99%
“…[189] Although GAG-based hydrogels have been employed for the parallel release of multiple growth factors, studies have shown that the sequential delivery of multiple growth factors would better mimic the temporal profile of the natural healing process. [190] Motivated by recent advances in hierarchically structured, multicomponent hydrogels and orthogonal degradation chemistries, GAG-based hydrogels with sequential release characteristics could be designed by incorporating a secondary nanoparticle domain (e.g., liposomes or PLGA nanoparticles) [191] into a GAG-based network and introducing multiple degradable linkages (e.g., wavelength-selective photocleavable units) [192] into the precursors. Combined with the inherent biological activities of GAGs, such GAG-based materials could provide physiologically relevant release profiles and spatial gradients of multiple growth factors, with the potential to improve tissue regeneration.…”
Section: Perspectivementioning
confidence: 99%
“…[1,2] Naturally, molecules pass across biological membranes by either active transport [3][4][5][6] or passive diffusion. [19][20][21][22][23][24][25][26][27][28] However, artificial membrane channels created so far mainly rely on complicated chemical synthesis and are inefficient to dynamically control the transport process. [19][20][21][22][23][24][25][26][27][28] However, artificial membrane channels created so far mainly rely on complicated chemical synthesis and are inefficient to dynamically control the transport process.…”
Section: Doi: 101002/marc201900518mentioning
confidence: 99%
“…[7][8][9] With the advent of new methods capable of mimicking and regulating transmembrane transport, [10][11][12][13][14][15][16][17][18] various biosensors, separation membranes, and drug carriers have been developed for diagnosis and treatments. [19][20][21][22][23][24][25][26][27][28] However, artificial membrane channels created so far mainly rely on complicated chemical synthesis and are inefficient to dynamically control the transport process. [29,30] showed that LLHs fully embedded with homogeneously distributed liposomes in an average size of 184 ± 41 nm ( Figure 2c).…”
mentioning
confidence: 99%
“…153 The enhanced stability permits release of encapsulated cargo molecules over longer timescales (ca. 3–6 days), 153, 154 demonstrating significant promise for tailoring therapeutic release within tumor microenvironments.…”
Section: Control Over Dynamic Functionalitymentioning
confidence: 99%